[ Price : $8.95]
FDA issues an updated alert about an ongoing Class 1 recall of certain BD Alaris Pump Module infusion sets due to device performan...[ Price : $8.95]
FDA commissioner Marty Makary tells agency employees that they are protected from planned mass workforce firings if a government s...[ Price : $8.95]
FDA posts a draft guidance to help drugmakers design clinical trials for treatments targeting disseminated coccidioidomycosis, als...[ Price : $8.95]
Larimar Therapeutics reports encouraging long-term data from its open-label study of nomlabofusp, an investigational therapy for F...[ Price : $8.95]
Novo Nordisk refiles its BLA for Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with Type 2 diabetes.[ Price : $8.95]
FDA tells IO Biotech not to submit a BLA for its experimental cancer vaccine Cylembio based on results from a recently completed P...[ Price : $8.95]
FDA expands its medical device Early Alert program to cover all products that may pose significant safety risks.[ Price : $8.95]
CDER director George Tidmarsh urges more compliance with clinical trial reporting requirements through the Clinicaltrials.gov gate...